Author

Umme Lubaba

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Cheng Chih HsuiD· 1 shared Fei JiangiD· 1 shared Haichang LiiD· 1 shared Hunter PiegolsiD· 1 shared Jiànróng LǐiD· 1 shared Li ZhaoiD· 1 shared Meng Bu· 1 shared Peihui Lin· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Cheng Chih HsuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineering Oncolytic Measles Virus with MG53 Couples Pyroptotic Tumor Killing with Immune Microenvironment Remodeling to Enhance Checkpoint Immunotherapy in Non-small Cell Lung Cancer

Zhongguang Li, Cheng Chih Hsu, Fei Jiang, Meng Bu, Umme Lubaba, S Li, Li Zhao, Peihui Lin, Hunter Piegols, Xuefeng Liu, Jiànróng Lǐ, Haichang Li

This paper engineers an oncolytic measles virus expressing MG53 to induce pyroptosis and immune remodeling, enhancing checkpoint immunotherapy in NSCLC.

bioRxiv · Jul 21, 2026 · PreprintImmunology